TP53 and cancer: Importantly, interference with the nucleolar integrity has been employed in the development of anti-cancer approaches, leading to the discovery of small molecules, CX-3543 and CX-5461, which selectively suppress tumor growth through the nucleolar stress-p53 signaling pathway by inhibiting RNA Pol I-dependent transcription [62,63].